Godsey & Gibb Associates Abbott Laboratories Transaction History

Godsey & Gibb Associates

$1.04 Billion
Q3 2024

A detailed history of Godsey & Gibb Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Godsey & Gibb Associates holds 3,201 shares of ABT stock, worth $361,072. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,201

Previous 3,341 4.19%

Holding current value

$361,072

Previous $347,000 4.9%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $14,009 - $16,538	-140 Reduced 4.19%	3,201 $364,000
Q2 2024 Jul 23, 2024	BUY	$100.73 - $112.44 $125,912 - $140,550	1,250 Added 59.78%	3,341 $347,000
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $16,428 - $18,144	150 Added 7.73%	2,091 $237,000
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $12,265 - $15,014	-136 Reduced 6.55%	1,941 $213,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $36,779 - $44,128	-385 Reduced 15.64%	2,077 $201,000
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $20,156 - $22,458	200 Added 8.84%	2,462 $268,000
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $219,097 - $257,890	2,262 New	2,262 $229,000
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $3,648 - $4,449	32 Added 1.52%	2,131 $252,000
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $11,553 - $14,146	-100 Reduced 4.55%	2,099 $295,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $17,499 - $19,359	-150 Reduced 6.39%	2,199 $260,000
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $109,598 - $129,013	-1,036 Reduced 30.61%	2,349 $272,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $368,423 - $434,058	3,385 New	3,385 $406,000
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $388,449 - $457,652	-3,569 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $21,420 - $23,341	204 Added 6.06%	3,569 $391,000
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $59,566 - $72,338	-650 Reduced 16.19%	3,365 $366,000
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $9,954 - $12,740	-130 Reduced 3.14%	4,015 $367,000
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $37,817 - $55,299	602 Added 16.99%	4,145 $327,000
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $59,196 - $65,899	-754 Reduced 17.55%	3,543 $308,000
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $9,002 - $9,761	-110 Reduced 2.5%	4,297 $360,000
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $321,182 - $374,595	4,407 New	4,407 $371,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.

Account

Godsey & Gibb Associates Abbott Laboratories Transaction History